Next 10 |
2024-05-15 17:09:42 ET More on Kodiak Sciences Kodiak Sciences Inc. (KOD) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kodiak Sciences ...
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif. , May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the qu...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to r...
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform PR Newswire Tarcocimab clinical and non-clinical data high...
2024-04-19 17:56:39 ET Gainers: BGC Group ( BGC ) +8% . Taboola ( TBLA ) +5% . Lam Research Corporation ( LRCX ) +4% . Kodiak Sciences ( KOD ) +3% . Leonardo ( DRS ) +3% . Losers: Rani Therapeutics ...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 14.4% to $1.04 on volume of 163,835,451 shares S&P 500 ETF TRUST ETF (SPY) fell 0.0% to $523.07 on volume of 96,294,886 shares Gamida Cell Ltd. (GMDA) fell 39.0% to $0.0361 on volume of 89,181,214 sh...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 14.4% to $1.04 on volume of 163,835,451 shares S&P 500 ETF TRUST ETF (SPY) fell 0.0% to $523.07 on volume of 96,294,886 shares Gamida Cell Ltd. (GMDA) fell 39.0% to $0.0361 on volume of 89,181,214 sh...
2024-03-28 20:57:08 ET Kodiak Sciences Inc. (KOD) Q4 2023 Results Conference Call March 28, 2024 04:30 PM ET Company Participants John Borgeson - CFO Victor Perlroth - Chairman and CEO Pablo Velasquez Martin - SVP of Clinical Research and Development Confer...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 14.4% to $1.04 on volume of 161,901,639 shares S&P 500 ETF TRUST ETF (SPY) fell 0.0% to $523.07 on volume of 91,101,164 shares Biodexa Pharmaceuticals plc (BDRX) rose 88.6% to $1.62 on volume of 87,7...
2024-03-28 16:20:10 ET More on Kodiak Sciences Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kodiak Sciences Read the full article on Seeking Alpha For further details see...
News, Short Squeeze, Breakout and More Instantly...
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results PR Newswire PALO ALTO, Calif. , May 15, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the qu...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy PR Newswire PALO ALTO, Calif. , May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to r...
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform PR Newswire Tarcocimab clinical and non-clinical data high...